Proteomic-based identification of HSP70 as a tumor-associated antigen in ovarian cancer. 2017

Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
Center for Tumor Biotherapy, The First Affiliated Hospital and College of Public Health, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.

Ovarian cancer commonly presents without prominent symptoms and is consequently diagnosed at advanced stages with unfavorable prognosis. Novel serological biomarkers for the early detection and clinical management of ovarian cancer are imminently needed. Proteomic-based methods for biomarker discovery are promising strategies implemented in cancer research. The aim of the present study was to identify new tumor antigens from the ovarian cancer cell line SKOV3 and their associated autoantibodies in sera of patients with ovarian cancer employing proteomic-based approaches. Proteins from the ovarian cancer cell line SKOV3 were extracted by two‑dimensional polyacrylamide gel electrophoresis (2-DE) followed by western blotting and antibody reaction with sera from patients with ovarian cancer and normal controls. Positive spots were excised from Coomassie blue‑stained gels and identified by liquid chromatography‑tandem mass spectrometry (LC-MS/MS). The 2-DE analysis results revealed a total of 14 protein spots on the gel, and 7 proteins were finally identified by LC-MS/MS. In the subsequent experiment, using immunoassay on ovarian cancer sera and tissue-array slides, the well-known protein HSP70 was selected in order to validate this proteomic-based approach. In conclusion, the proteomic method used in the present study is a powerful instrument for identifying novel serum markers that may exhibit clinical usefulness in cancer.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D046888 Tissue Array Analysis The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips. Cell Array Analysis,Cell Microarray Analysis,Tissue Microarray Analysis,Analyses, Cell Array,Analyses, Cell Microarray,Analyses, Tissue Array,Analyses, Tissue Microarray,Analysis, Cell Array,Analysis, Cell Microarray,Analysis, Tissue Array,Analysis, Tissue Microarray,Array Analyses, Cell,Array Analyses, Tissue,Array Analysis, Cell,Array Analysis, Tissue,Cell Array Analyses,Cell Microarray Analyses,Microarray Analyses, Cell,Microarray Analyses, Tissue,Microarray Analysis, Cell,Microarray Analysis, Tissue,Tissue Array Analyses,Tissue Microarray Analyses
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell
D018840 HSP70 Heat-Shock Proteins A class of MOLECULAR CHAPERONES found in both prokaryotes and in several compartments of eukaryotic cells. These proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures. Heat-Shock Proteins 70,Heat Shock 70 kDa Protein,Heat-Shock Protein 70,HSP70 Heat Shock Proteins,Heat Shock Protein 70,Heat Shock Proteins 70,Heat-Shock Proteins, HSP70
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
March 2007, Proteomics. Clinical applications,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
March 2009, Cancer letters,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
March 1977, New York state journal of medicine,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
August 2011, Oncogene,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
July 2004, British journal of cancer,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
February 2007, The Prostate,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
November 2009, International journal of colorectal disease,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
January 2012, Current pharmaceutical design,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
May 2014, World journal of gastroenterology,
Xin-Xin Liu, and Hua Ye, and Peng Wang, and Liu-Xia Li, and Yi Zhang, and Jian-Ying Zhang
April 2010, Oncology reports,
Copied contents to your clipboard!